Taylor & Francis

Expert Opinion on Drug Safety Template

Write in a clean editor, then format for Expert Opinion on Drug Safety in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Expert Opinion on Drug Safety format

Expert Opinion on Drug Safety is a peer-reviewed journal published by Taylor & Francis, covering Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions, Diabetes Treatment and Management.

PublisherTaylor & Francis
Reference styleAuthor–year (Chicago, T&F)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Drug Safety 12 (3): 45–58.

Formats any DOI in Expert Opinion on Drug Safety style. No sign-up.

Publishes research inPharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions Diabetes Treatment and Management Rheumatoid Arthritis Research and Therapies Pharmaceutical studies and practices
ISSN1474-0338
Citation impact (2-yr)3.16
h-index111
i10-index1,755
Total citations80,212
Top institutions publishing hereWeatherford College
Journal websiteinformahealthcare.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Expert Opinion on Drug Safety per year

184
2014
179
2015
182
2016
140
2017
115
2018
124
2019
174
2020
170
2021
109
2022
176
2023
302
2024
212
2025

Citation impact of Expert Opinion on Drug Safety by publication year

6K
2014
5.7K
2015
6.4K
2016
4.5K
2017
3.6K
2018
3.6K
2019
3.6K
2020
2.6K
2021
1.7K
2022
1.5K
2023
1.3K
2024
336
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Expert Opinion on Drug Safety

Clinical consequences of polypharmacy in elderly

Robert L. Maher, Joseph T. Hanlon, Emily Hajjar · 27 Sep 2013

INTRODUCTION: Polypharmacy, defined as the use of multiple drugs or more than are medically necessary, is a growing concern for older adults. MEDLINE and EMBASE databases were searched from January 1, 1986 to June 30, 2013) to identify relevant articles in people aged > 65 years. AREAS COVERED: We present information about: i) prevalence of…

1,911 citations Cite SaveGo to paper →
Long-term side effects of glucocorticoids

Merih Oray, Khawla Abu Samra, Nazanin Ebrahimiadib et al. · 20 Jan 2016

INTRODUCTION: Glucocorticoids represent the standard therapy for reducing inflammation and immune activation in various diseases. However, as with any potent medication, they are not without side effects. Glucocorticoid-associated side effects may involve most major organ systems. Musculoskeletal, gastrointestinal, cardiovascular, endocrine, neuropsychiatric, dermatologic, ocular, and immunologic side effects are all possible. AREAS COVERED: This article analyzes…

Paclitaxel: a review of adverse toxicities and novel delivery strategies

Neena I. Marupudi, James E. Han, Khan W. Li et al. · 1 Sep 2007

Better known as Taxol (Bristol-Myers Squibb), paclitaxel is the first member of the taxane family to be used in cancer chemotherapy. The taxanes exert their cytotoxic effect by arresting mitosis through microtubule stabilization, resulting in cellular apoptosis. The use of paclitaxel as a chemotherapeutic agent has become a broadly accepted option in the treatment of…

A review of existing and emerging digital technologies to combat the global trade in fake medicines

Tim K. Mackey, Gaurvika M. L. Nayyar · 28 Mar 2017

INTRODUCTION: The globalization of the pharmaceutical supply chain has introduced new challenges, chief among them, fighting the international criminal trade in fake medicines. As the manufacture, supply, and distribution of drugs becomes more complex, so does the need for innovative technology-based solutions to protect patients globally. Areas covered: We conducted a multidisciplinary review of the…

Hydroxychloroquine in systemic lupus erythematosus (SLE)

Claudio Ponticelli, Gabriella Moroni · 8 Dec 2016

INTRODUCTION: Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by increasing the pH. HCQ has proved to be effective in a number of autoimmune diseases including systemic lupus erythematosus (SLE). Areas covered: In this review the mechanisms of action, the efficacy, and the safety of HCQ…

Expert Opinion on Drug Safety template — frequently asked questions

How do I write a paper in the Expert Opinion on Drug Safety format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Expert Opinion on Drug Safety template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Expert Opinion on Drug Safety use?
Expert Opinion on Drug Safety uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Drug Safety 12 (3): 45–58.
Do I need to know LaTeX to submit to Expert Opinion on Drug Safety?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready Expert Opinion on Drug Safety document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Expert Opinion on Drug Safety template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Expert Opinion on Drug Safety format with correct headings, figures, tables, and author–year citations.
Who publishes Expert Opinion on Drug Safety?
Expert Opinion on Drug Safety is a multidisciplinary journal published by Taylor & Francis. DocuGuru's Expert Opinion on Drug Safety template matches Taylor & Francis's official submission format.
Can I export a submission-ready Expert Opinion on Drug Safety PDF?
Yes — DocuGuru produces a PDF built with the official Expert Opinion on Drug Safety template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the Expert Opinion on Drug Safety template cost?
You can start writing in the Expert Opinion on Drug Safety template for free. Exporting the final submission-ready Expert Opinion on Drug Safety PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Expert Opinion on Drug Safety template